Atombeat and BioDuro have announced a strategic partnership to launch an AI-powered platform aimed at accelerating peptide ...

A new study from researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) reveals that ...

On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, ...

This platform aims to deliver high-quality cyclic peptides with faster timelines and better economy across a broad range of ...

A new study from researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) reveals that extremely simple peptides can mimic a biological process that protects ...

BioDuro & Atombeat enter strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery: Irvine, California Saturday, August 2, 2025, 16:00 Hrs [IST ...

New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...

A breakthrough for the customized treatment of cancer and other diseases is so promising that University of Washington ...

A new study from researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) reveals that ...

In the realm of peptide-based research, few compounds have garnered as much interdisciplinary interest as BPC-157. This synthetic pentadecapeptide, derived from a partial sequence of a protein ...